{"name": "NovImmune",
 "permalink": "novimmune",
 "crunchbase_url": "http://www.crunchbase.com/company/novimmune",
 "homepage_url": "http://www.novimmune.com/",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": 1998,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "Contact@novimmune.com",
 "phone_number": "+41 22 839 71 41",
 "description": "Therapeutic monoclonal antibodies",
 "created_at": "Wed Jun 17 21:31:52 UTC 2009",
 "updated_at": "Sat Dec 18 02:37:20 UTC 2010",
 "overview": "\u003Cp\u003ENovImmmune is committed to innovation by discovering and developing therapeutic monoclonal antibodies (mAbs) to treat patients suffering from immune-related disorders.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       44],
      "assets/images/resized/0004/9228/49228v1-max-150x150.png"],
     [[250,
       74],
      "assets/images/resized/0004/9228/49228v1-max-250x250.png"],
     [[262,
       78],
      "assets/images/resized/0004/9228/49228v1-max-450x450.png"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "CEO",
    "person":
     {"first_name": "Jack",
      "last_name": "Barbut",
      "permalink": "jack-barbut",
      "image": null}},
   {"is_past": false,
    "title": "CMO",
    "person":
     {"first_name": "Penny",
      "last_name": "Ward",
      "permalink": "penny-ward",
      "image": null}},
   {"is_past": false,
    "title": "CFO",
    "person":
     {"first_name": "Arnd",
      "last_name": "Christ",
      "permalink": "arnd-christ",
      "image": null}},
   {"is_past": false,
    "title": "CSO",
    "person":
     {"first_name": "Marie",
      "last_name": "Kosco-Vilbois",
      "permalink": "marie-kosco-vilbois",
      "image": null}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$155M",
 "funding_rounds":
  [{"round_code": "a",
    "source_url": "http://www.novimmune.com/about-us/history.html",
    "source_description": "Company History",
    "raised_amount": 14000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2000,
    "funded_month": 5,
    "funded_day": null,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Novartis Venture Fund",
         "permalink": "novartis-venture-fund",
         "image":
          {"available_sizes":
            [[[150,
               70],
              "assets/images/resized/0005/9083/59083v2-max-150x150.png"],
             [[250,
               117],
              "assets/images/resized/0005/9083/59083v2-max-250x250.png"],
             [[318,
               150],
              "assets/images/resized/0005/9083/59083v2-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "LODH Immunology Fund",
         "permalink": "lodh-immunology-fund",
         "image": null},
       "person": null}]},
   {"round_code": "b",
    "source_url": "http://www.novimmune.com/about-us/history.html",
    "source_description": "Company History",
    "raised_amount": 13000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2005,
    "funded_month": 2,
    "funded_day": null,
    "investments":
     []},
   {"round_code": "c",
    "source_url": "http://www.novimmune.com/about-us/history.html",
    "source_description": "Company History",
    "raised_amount": 53000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2006,
    "funded_month": 6,
    "funded_day": null,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "BZ Bank",
         "permalink": "bz-bank",
         "image":
          {"available_sizes":
            [[[108,
               87],
              "assets/images/resized/0005/8240/58240v1-max-150x150.png"],
             [[108,
               87],
              "assets/images/resized/0005/8240/58240v1-max-250x250.png"],
             [[108,
               87],
              "assets/images/resized/0005/8240/58240v1-max-450x450.png"]],
           "attribution": null}},
       "person": null}]},
   {"round_code": "d",
    "source_url": "http://onbiovc.com/novimmune-sa-series-c-548m/",
    "source_description": "NovImmune, SA: Series C $54.8M",
    "raised_amount": 54800000.0,
    "raised_currency_code": "USD",
    "funded_year": 2009,
    "funded_month": 5,
    "funded_day": 12,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "BZ Bank",
         "permalink": "bz-bank",
         "image":
          {"available_sizes":
            [[[108,
               87],
              "assets/images/resized/0005/8240/58240v1-max-150x150.png"],
             [[108,
               87],
              "assets/images/resized/0005/8240/58240v1-max-250x250.png"],
             [[108,
               87],
              "assets/images/resized/0005/8240/58240v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Novartis Venture Fund",
         "permalink": "novartis-venture-fund",
         "image":
          {"available_sizes":
            [[[150,
               70],
              "assets/images/resized/0005/9083/59083v2-max-150x150.png"],
             [[250,
               117],
              "assets/images/resized/0005/9083/59083v2-max-250x250.png"],
             [[318,
               150],
              "assets/images/resized/0005/9083/59083v2-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "LODH Immunology Fund",
         "permalink": "lodh-immunology-fund",
         "image": null},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Varuma AG",
         "permalink": "varuma-ag",
         "image":
          {"available_sizes":
            [[[150,
               38],
              "assets/images/resized/0006/3739/63739v1-max-150x150.jpg"],
             [[150,
               38],
              "assets/images/resized/0006/3739/63739v1-max-250x250.jpg"],
             [[150,
               38],
              "assets/images/resized/0006/3739/63739v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Pictet Private Equity Investors S.A.",
         "permalink": "pictet-private-equity-investors-s-a",
         "image":
          {"available_sizes":
            [[[150,
               60],
              "assets/images/resized/0006/1789/61789v1-max-150x150.png"],
             [[150,
               60],
              "assets/images/resized/0006/1789/61789v1-max-250x250.png"],
             [[150,
               60],
              "assets/images/resized/0006/1789/61789v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Ingro Finanz AG",
         "permalink": "ingro-finanz-ag",
         "image": null},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Aravis Ventures",
         "permalink": "aravis-ventures",
         "image":
          {"available_sizes":
            [[[150,
               27],
              "assets/images/resized/0004/8028/48028v2-max-150x150.png"],
             [[208,
               38],
              "assets/images/resized/0004/8028/48028v2-max-250x250.png"],
             [[208,
               38],
              "assets/images/resized/0004/8028/48028v2-max-450x450.png"]],
           "attribution": null}},
       "person": null}]},
   {"round_code": "b",
    "source_url": "http://www.novimmune.com/geneva-switzerland-december-17th-2010-2.html",
    "source_description": "NovImmune raises additional CHF 20 million ",
    "raised_amount": 20600000.0,
    "raised_currency_code": "USD",
    "funded_year": 2010,
    "funded_month": 12,
    "funded_day": 17,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "BZ Bank",
         "permalink": "bz-bank",
         "image":
          {"available_sizes":
            [[[108,
               87],
              "assets/images/resized/0005/8240/58240v1-max-150x150.png"],
             [[108,
               87],
              "assets/images/resized/0005/8240/58240v1-max-250x250.png"],
             [[108,
               87],
              "assets/images/resized/0005/8240/58240v1-max-450x450.png"]],
           "attribution": null}},
       "person": null}]}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "",
    "address2": "",
    "zip_code": "",
    "city": "Geneva",
    "state_code": null,
    "country_code": "CHE",
    "latitude": 46.2038099,
    "longitude": 6.1399589}],
 "milestones":
  [{"description": "NovImmune inks deal, eyes possible IPO",
    "stoned_year": 2010,
    "stoned_month": 7,
    "stoned_day": 26,
    "source_url": "http://www.fiercebiotech.com/story/novimmune-inks-deal-eyes-possible-ipo/2010-07-26?utm_medium=rss\u0026utm_source=rss",
    "source_text": "",
    "source_description": "NovImmune inks deal, eyes possible IPO",
    "stoneable_type": "Company",
    "stoned_value": null,
    "stoned_value_type": null,
    "stoned_acquirer": null,
    "stoneable":
     {"name": "NovImmune",
      "permalink": "novimmune"}}],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [{"available_sizes":
     [[[150,
        102],
       "assets/images/resized/0004/9227/49227v1-max-150x150.png"],
      [[250,
        170],
       "assets/images/resized/0004/9227/49227v1-max-250x250.png"],
      [[450,
        307],
       "assets/images/resized/0004/9227/49227v1-max-450x450.png"]],
    "attribution": null}],
 "external_links":
  []}